Predictors of long-term survival in patients with malignant ventricular arrhythmias.

The study consisted of 369 patients (age 62 +/- 13 years) who presented to our institution from April 1984 to April 1994 for malignant ventricular arrhythmias presenting as sustained ventricular tachycardia (VT) in 57% of patients, ventricular fibrillation in 25% of patients, and syncope due to VT in 17% of patients. Coronary artery disease was present in 74% of patients, cardiomyopathy in 19% of patients, and no evident heart disease in 7% of patients. Two hundred twenty-one patients were given drug, therapy, 47 patients underwent arrhythmia surgery, and 75 patients had an implantable cardioverter-defibrillator (ICD). During a mean follow-up of 30 months (range 1 to 101), 66 patients (18%) died from a cardiac death of which 26 (39%) were sudden. Cox regression analysis was conducted utilizing a total of 19 variables (clinical and therapeutic) in the entire population and separately in patients with coronary artery disease and cardiomyopathy. The most significant variables (multivariate analysis) of survival from cardiac mortality in the entire population were: congestive heart failure (CHF) class (p = 0.0003), ejection fraction (p = 0.02), and the use of drug therapy (p = 0.03); in patients with coronary artery disease, CHF class (p = 0.0001) and ejection fraction (p = 0.0006); and in patients with cardiomyopathy, CHF class (p = 0.009) and sustained VT on Holter monitoring (p = 0.007). Kaplan-Meier survival rates from cardiac death were: significantly lower (p = 0.005) in patients with CHF class III and IV compared with CHF class I and II (25% vs 58%, p = 0.005) with drug therapy; marginally significant (47% vs 88%, p = 0.06) from 20 to 40 months in patients with an ICD; and nonsignificant in patients who underwent arrhythmia surgery (63% vs 71%). Patients with an ICD had a better expected survival (82%) than patients who had arrhythmia surgery (69%) and drug therapy (65%). Thus, in patients with malignant ventricular arrhythmias, CHF class was the most significant independent predictor of survival from cardiac mortality over all disease substrates, and therapy influenced survival depending on the CHF class. Patients in CHF class III and IV who underwent arrhythmia surgery or had an ICD had a better expected survival than those taking drug therapy, and the negative impact of antiarrhythmic therapy was most prominent in patients with CHF class III and IV.

[1]  R. Fogoros,et al.  The automatic implantable cardioverter-defibrillator in drug-refractory ventricular tachyarrhythmias. , 1987, Annals of internal medicine.

[2]  W. Weaver,et al.  Influence of coronary bypass surgery on subsequent outcome of patients resuscitated from out of hospital cardiac arrest. , 1992, Journal of the American College of Cardiology.

[3]  R. Cappato,et al.  ICD versus Drugs in Cardiac Arrest Survivors: Preliminary Results of the Cardiac Arrest Study Hamburg , 1993, Pacing and clinical electrophysiology : PACE.

[4]  S. Saksena,et al.  Survival of implantable cardioverter-defibrillator recipients: role of left ventricular function and its relationship to device use. , 1992, American heart journal.

[5]  J. Ruskin,et al.  Influence of implantable cardioverter-defibrillators on the long-term prognosis of survivors of out-of-hospital cardiac arrest. , 1993, Circulation.

[6]  M. Domanski,et al.  Antiarrhythmics Versus Implantable Defibrillators (AVID)--rationale, design, and methods. , 1995, The American journal of cardiology.

[7]  F. Tristani,et al.  Effect of Vasodilator Therapy on Mortality in Chronic Congestive Heart Failure , 1986 .

[8]  B. Gersh,et al.  The effect of medical and surgical treatment on subsequent sudden cardiac death in patients with coronary artery disease: a report from the Coronary Artery Surgery Study. , 1986, Circulation.

[9]  J. Fisher,et al.  Comparison of defibrillator therapy and other therapeutic modalities for sustained ventricular tachycardia or ventricular fibrillation associated with coronary artery disease. , 1994, The American journal of cardiology.

[10]  H. Crijns,et al.  Cost-effectiveness of implantable defibrillator as first-choice therapy versus electrophysiologically guided, tiered strategy in postinfarct sudden death survivors. A randomized study. , 1996, Circulation.

[11]  J. Ruskin,et al.  Mortality benefits and the implantable cardioverter-defibrillator. , 1994, Circulation.

[12]  J. Ruskin,et al.  Surgical coronary revascularization in survivors of prehospital cardiac arrest: its effect on inducible ventricular arrhythmias and long-term survival. , 1990, Journal of the American College of Cardiology.

[13]  J. Machac,et al.  Coronary bypass with ejection fraction of 0.20 or less using centigrade cardioplegia: long-term follow-up. , 1993, The Annals of thoracic surgery.

[14]  E. Downar,et al.  Late results of operation for ventricular tachycardia. , 1992, The Annals of thoracic surgery.

[15]  The CASCADE Study: randomized antiarrhythmic drug therapy in survivors of cardiac arrest in Seattle. CASCADE Investigators. , 1993, The American journal of cardiology.

[16]  J. Ruskin,et al.  Out-of-hospital cardiac arrest. Use of electrophysiologic testing in the prediction of long-term outcome. , 1988, The New England journal of medicine.

[17]  J. Langberg,et al.  Survival after implantation of the cardioverter defibrillator. , 1992, The American journal of cardiology.

[18]  A. Castellanos,et al.  Long-term survival after prehospital cardiac arrest: analysis of outcome during an 8 year study. , 1984, Circulation.

[19]  J. Fisher,et al.  Long-term outcomes and modes of death of patients treated with nonthoracotomy implantable defibrillators. , 1995, The American journal of cardiology.

[20]  P. Tchou,et al.  Automatic implantable cardioverter defibrillators and survival of patients with left ventricular dysfunction and malignant ventricular arrhythmias. , 1988, Annals of internal medicine.

[21]  P. Kudenchuk,et al.  Long-term outcome in patients who survive out of hospital ventricular fibrillation and undergo electrophysiologic studies: evaluation by electrophysiologic subgroups. , 1990, Journal of the American College of Cardiology.

[22]  L. Cupples,et al.  Multiple testing of hypotheses in comparing two groups. , 1984, Annals of internal medicine.

[23]  D. Cox.  Regression Models and Life-Tables , 1972 .

[24]  R. Winkle,et al.  Long-term outcome with the automatic implantable cardioverter-defibrillator. , 1989, Journal of the American College of Cardiology.